We are live on ! Find out more
DILIC

Dai-ichi Life Insurance Company Portfolio holdings

AUM $4.28B
1-Year Est. Return 43.07%
This Fund
S&P 500
This Quarter Est. Return
+18.32%
1 Year Est. Return
+43.07%
3 Year Est. Return
+128.05%
5 Year Est. Return
+141.4%
10 Year Est. Return
AUM
$4.37B
AUM Growth
+$1.77B
Cap. Flow
+$1.21B
Cap. Flow %
27.68%
Top 10 Hldgs %
44.27%
Holding
520
New
26
Increased
100
Reduced
322
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 15.94%
2 Healthcare 9.81%
3 Consumer Discretionary 8.84%
4 Financials 8.72%
5 Communication Services 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
51
Morgan Stanley
MS
$342B
$16.2M 0.37%
335,460
-5,567
-2% -$234K
VRTX icon
52
Vertex Pharmaceuticals
VRTX
$133B
$16.1M 0.37%
55,491
+33,965
+158% +$9.21M
SUI icon
53
Sun Communities
SUI
$14.4B
$16M 0.37%
118,068
+95,965
+434% +$12.7M
CMCSA icon
54
Comcast
CMCSA
$90.4B
$15.9M 0.36%
408,364
-95,153
-19% -$3.62M
NKE icon
55
Nike
NKE
$60.1B
$15.7M 0.36%
159,651
-6,355
-4% -$587K
C icon
56
Citigroup
C
$231B
$15.4M 0.35%
302,299
-47,390
-14% -$2.25M
ZTS icon
57
Zoetis
ZTS
$30.4B
$14.9M 0.34%
109,042
-731
-0.7% -$95.4K
TXN icon
58
Texas Instruments
TXN
$253B
$14.9M 0.34%
117,054
+1,534
+1% +$179K
LOW icon
59
Lowe's Companies
LOW
$121B
$14.1M 0.32%
104,281
+10,078
+11% +$1.15M
SPGI icon
60
S&P Global
SPGI
$121B
$13.1M 0.3%
39,818
-887
-2% -$267K
TMO icon
61
Thermo Fisher Scientific
TMO
$223B
$13.1M 0.3%
36,181
-4,420
-11% -$1.48M
ABBV icon
62
AbbVie
ABBV
$440B
$13M 0.3%
132,026
+26,039
+25% +$2.29M
FIS icon
63
Fidelity National Information Services
FIS
$21.6B
$12.9M 0.3%
96,556
+22,082
+30% +$2.9M
EQIX icon
64
Equinix
EQIX
$105B
$12.9M 0.3%
18,415
-241
-1% -$163K
BMY icon
65
Bristol-Myers Squibb
BMY
$130B
$12.9M 0.29%
218,672
-2,885
-1% -$173K
ABT icon
66
Abbott
ABT
$192B
$12.8M 0.29%
139,959
-31,409
-18% -$2.84M
ELS icon
67
Equity Lifestyle Properties
ELS
$12.4B
$12.6M 0.29%
202,332
+160,157
+380% +$9.84M
APD icon
68
Air Products & Chemicals
APD
$67.7B
$12.1M 0.28%
49,956
+533
+1% +$122K
REGN icon
69
Regeneron Pharmaceuticals
REGN
$82.2B
$11.9M 0.27%
19,116
+9,803
+105% +$5.56M
ORCL icon
70
Oracle
ORCL
$442B
$11.9M 0.27%
214,516
-5,330
-2% -$282K
AVGO icon
71
Broadcom
AVGO
$1.98T
$11.8M 0.27%
375,330
-7,370
-2% -$206K
NEM icon
72
Newmont
NEM
$124B
$11.8M 0.27%
191,829
-31,905
-14% -$1.89M
EWZ icon
73
iShares MSCI Brazil ETF
EWZ
$8.57B
$11.6M 0.27%
404,700
+362,000
+848% +$9.49M
GS icon
74
Goldman Sachs
GS
$302B
$11.4M 0.26%
57,649
-834
-1% -$157K
TSLA icon
75
Tesla
TSLA
$1.29T
$11.3M 0.26%
156,795
-1,575
-1% -$85.2K

Similar funds

Dai-ichi Life Insurance Company's Q2 2020 Portfolio in Review

As of Q2 2020, Dai-ichi Life Insurance Company held 520 positions worth $4.37B, up 68% from $2.61B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Dai-ichi Life Insurance Company deployed $1.21B of net new capital in Q2 2020, opening 26 new positions and adding to 100 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 7,876,500 shares worth $749M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $11.1M trimmed.

  • Dai-ichi Life Insurance Company's largest Q2 2020 buy was Vanguard Intermediate-Term Corporate Bond ETF: 7,876,500 shares worth $749M.
  • Dai-ichi Life Insurance Company added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $344M increase.
  • Dai-ichi Life Insurance Company's biggest Q2 2020 reduction was Microsoft, cutting an estimated $11.1M.
  • Dai-ichi Life Insurance Company fully exited iShares Russell 1000 ETF in Q2 2020, selling an estimated $46.1M.
  • Dai-ichi Life Insurance Company's ten largest holdings make up 44% of its $4.37B portfolio in Q2 2020.
  • Dai-ichi Life Insurance Company opened 26 new positions and closed 25 in Q2 2020.
  • Dai-ichi Life Insurance Company's portfolio value rose 68% quarter-over-quarter to $4.37B.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2020, filed 12 Aug 2020.